Synthesis and Characterization of 8-Nitroguanosine 3′,5′-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α-Reference-Cited by-同舟云学术

Synthesis and Characterization of 8-Nitroguanosine 3′,5′-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α

Published:2017 Issue:3 Volume:40 Page:365-374
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ahmed Khandaker Ahtesham¹,Zhang Tianli²,Ono Katsuhiko²,Tsutsuki Hiroyasu²,Ida Tomoaki³,Akashi Soichiro³,Miyata Keishi⁴,Oike Yuichi⁴,Akaike Takaaki³,Sawa Tomohiro²

Affiliation:

1. Department of Pathology, University of Alabama at Birmingham

2. Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University

3. Department of Environmental Health Sciences and Molecular Toxicology, Tohoku University Graduate School of Medicine

4. Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/3/40_b16-00880/_pdf

Reference35 articles.

1. 1) Francis SH, Busch JL, Corbin JD, Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev., 62, 525–563 (2010).

2. 2) Smolenski A, Burkhardt AM, Eigenthaler M, Butt E, Gambaryan S, Lohmann SM, Walter U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch. Pharmacol., 358, 134–139 (1998).

3. 3) Hofmann F, Bernhard D, Lukowski R, Weinmeister P. cGMP regulated protein kinases (cGK). Handb. Exp. Pharmacol., 191, 137–162 (2009).

4. 4) Wolfertstetter S, Huettner JP, Schlossmann J. cGMP-dependent protein kinase inhibitors in health and disease. Pharmaceuticals, 6, 269–286 (2013).

5. 5) Schwede F, Maronde E, Genieser H, Jastorff B. Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol. Ther., 87, 199–226 (2000).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bond Formation at C8 in the Nucleoside and Nucleotide Purine Scaffold: An Informative Selection;Molecules;2024-04-17

2. Essential role of ROS – 8-Nitro-cGMP signaling in long-term memory of motor learning and cerebellar synaptic plasticity;Redox Biology;2024-04

3. Redox Regulation of Xenobiotics by Reactive Sulfur and Supersulfide Species;Antioxidants & Redox Signaling;2023-09-05

4. Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP;Journal of Clinical Investigation;2023-09-01

5. Azolo substitution into the purine scaffold in nucleoside cyclic 3',5'-phosphorothioates;Monatshefte für Chemie - Chemical Monthly;2022-09-29